Literature DB >> 18085536

1,1-bis(3'-indolyl)-1-(p-substituted phenyl)methanes decrease mitochondrial membrane potential and induce apoptosis in endometrial and other cancer cell lines.

Jun Hong1, Ismael Samudio, Sudhakar Chintharlapalli, Stephen Safe.   

Abstract

1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes, containing p-t-butyl (DIM-C-pPhtBu) and phenyl (DIM-C-pPhC(6)H(5)) substituents, are peroxisome proliferator-activated receptor gamma (PPARgamma) agonists; however, DIM-C-pPhtBu-induced growth inhibition and cell death in human HEC1A endometrial cancer cells is PPARgamma-independent. DIM-C-pPhtBu decreased mitochondrial membrane potential (MMP) and promoted the release of cytochrome c and caspase activation and nuclear uptake of endonuclease G leading to apoptosis of HEC1A cells. DIM-C-pPhtBu specifically targeted the mitochondrial permeability transition pore complex (PTPC) because the DIM-C-pPhtBu-induced pro-apoptotic responses were inhibited by atractyloside (Atra), a compound that specifically interacts with the inner mitochondrial membrane adenine nucleotide transport (ANT) proteins. At the dose of Atra used in this study (300 microM), this compound alone did not alter the PTPC but inhibited the mitochondriotoxic effects of DIM-C-pPhtBu. DIM-C-pPhtBu/DIM-C-pPhC(6)H(5) and Atra also differentially affected the ability of eosin-5-maleimide (EMA) to alkylate Cys160 in the ANT protein and Atra, but not DIM-C-pPhtBu, inhibited the exchange of ATP/ADP in isolated mitochondria suggesting that these pharmacophores act on different sites on the ANT protein. Results of this study show that the receptor-independent proapoptotic activity of DIM-C-pPhtBu and DIM-C-pPhC(6)H(5) were related to novel mitochondriotoxic activities involving inner mitochondrial ANT proteins. Copyright 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18085536      PMCID: PMC2711558          DOI: 10.1002/mc.20407

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  61 in total

Review 1.  The adenine nucleotide translocator in apoptosis.

Authors:  Anne-Sophie Belzacq; Helena L A Vieira; Guido Kroemer; Catherine Brenner
Journal:  Biochimie       Date:  2002 Feb-Mar       Impact factor: 4.079

2.  15-Deoxy-delta12,14-prostaglandin J2-induced apoptosis does not require PPARgamma in breast cancer cells.

Authors:  Carl E Clay; Arta Monjazeb; Jacqueline Thorburn; Floyd H Chilton; Kevin P High
Journal:  J Lipid Res       Date:  2002-11       Impact factor: 5.922

3.  1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit ovarian cancer cell growth through peroxisome proliferator-activated receptor-dependent and independent pathways.

Authors:  Ping Lei; Maen Abdelrahim; Stephen Safe
Journal:  Mol Cancer Ther       Date:  2006-09       Impact factor: 6.261

4.  Chemosensitization by knockdown of adenine nucleotide translocase-2.

Authors:  Morgane Le Bras; Annie Borgne-Sanchez; Zahia Touat; Ossama Sharaf El Dein; Aurélien Deniaud; Evelyne Maillier; Gael Lecellier; Dominique Rebouillat; Christophe Lemaire; Guido Kroemer; Etienne Jacotot; Catherine Brenner
Journal:  Cancer Res       Date:  2006-09-15       Impact factor: 12.701

5.  Anticancer effects of thiazolidinediones are independent of peroxisome proliferator-activated receptor gamma and mediated by inhibition of translation initiation.

Authors:  S S Palakurthi; H Aktas; L M Grubissich; R M Mortensen; J A Halperin
Journal:  Cancer Res       Date:  2001-08-15       Impact factor: 12.701

6.  Bcl-2 family-mediated apoptotic effects of 3,3'-diindolylmethane (DIM) in human breast cancer cells.

Authors:  Chibo Hong; Gary L Firestone; Leonard F Bjeldanes
Journal:  Biochem Pharmacol       Date:  2002-03-15       Impact factor: 5.858

7.  Peroxisome proliferator-activated receptor gamma agonists induce proteasome-dependent degradation of cyclin D1 and estrogen receptor alpha in MCF-7 breast cancer cells.

Authors:  Chunhua Qin; Robert Burghardt; Roger Smith; Mark Wormke; Jessica Stewart; Stephen Safe
Journal:  Cancer Res       Date:  2003-03-01       Impact factor: 12.701

8.  Role of critical thiol groups on the matrix surface of the adenine nucleotide translocase in the mechanism of the mitochondrial permeability transition pore.

Authors:  Gavin P McStay; Samantha J Clarke; Andrew P Halestrap
Journal:  Biochem J       Date:  2002-10-15       Impact factor: 3.857

Review 9.  Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors.

Authors:  Chih-Hao Lee; Peter Olson; Ronald M Evans
Journal:  Endocrinology       Date:  2003-06       Impact factor: 4.736

10.  A novel adenine nucleotide translocase inhibitor, MT-21, induces cytochrome c release by a mitochondrial permeability transition-independent mechanism.

Authors:  Kiyotaka Machida; Yujiro Hayashi; Hiroyuki Osada
Journal:  J Biol Chem       Date:  2002-06-12       Impact factor: 5.157

View more
  7 in total

1.  Derivation of a retinoid X receptor scaffold from peroxisome proliferator-activated receptor gamma ligand 1-Di(1H-indol-3-yl)methyl-4-trifluoromethylbenzene.

Authors:  Marcia I Dawson; Mao Ye; Xihua Cao; Lulu Farhana; Qiong-Ying Hu; Yong Zhao; Li Ping Xu; Alice Kiselyuk; Ricardo G Correa; Li Yang; Tingjun Hou; John C Reed; Pamela Itkin-Ansari; Fred Levine; Michel F Sanner; Joseph A Fontana; Xiao-Kun Zhang
Journal:  ChemMedChem       Date:  2009-07       Impact factor: 3.466

2.  Suppression of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nitric-oxide synthase 2 expression in astrocytes by a novel diindolylmethane analog protects striatal neurons against apoptosis.

Authors:  David L Carbone; Katriana A Popichak; Julie A Moreno; Stephen Safe; Ronald B Tjalkens
Journal:  Mol Pharmacol       Date:  2008-10-07       Impact factor: 4.436

3.  The orphan nuclear receptor NR4A1 (Nur77) regulates oxidative and endoplasmic reticulum stress in pancreatic cancer cells.

Authors:  Syng-Ook Lee; Un-Ho Jin; Jeong Han Kang; Sang Bae Kim; Aaron S Guthrie; Sandeep Sreevalsan; Ju-Seog Lee; Stephen Safe
Journal:  Mol Cancer Res       Date:  2014-02-10       Impact factor: 5.852

4.  β-elemene reverses the drug resistance of A549/DDP lung cancer cells by activating intracellular redox system, decreasing mitochondrial membrane potential and P-glycoprotein expression, and inducing apoptosis.

Authors:  Chengcai Yao; Jie Jiang; Yuanrong Tu; Shefang Ye; Haoxin Du; Yi Zhang
Journal:  Thorac Cancer       Date:  2014-07-03       Impact factor: 3.500

5.  PPARs: Interference with Warburg' Effect and Clinical Anticancer Trials.

Authors:  Joseph Vamecq; Jean-Marie Colet; Jean Jacques Vanden Eynde; Gilbert Briand; Nicole Porchet; Stéphane Rocchi
Journal:  PPAR Res       Date:  2012-05-08       Impact factor: 4.964

Review 6.  Contribution of Mitochondrial DNA Variation to Chronic Disease in East Asian Populations.

Authors:  Dayan Sun; Yang Wei; Hong-Xiang Zheng; Li Jin; Jiucun Wang
Journal:  Front Mol Biosci       Date:  2019-11-15

7.  LASS2 regulates invasion and chemoresistance via ERK/Drp1 modulated mitochondrial dynamics in bladder cancer cells.

Authors:  Lijuan Huang; Ting Luan; Yujin Chen; Xin Bao; Yinglong Huang; Shi Fu; Haifeng Wang; Jiansong Wang
Journal:  J Cancer       Date:  2018-02-28       Impact factor: 4.207

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.